INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

71,196 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
AS
Arnzen April SEVP and Chief People Officer
MUMICRON TECHNOLOGY INC
Grant or award
A—
16.0K sh
Oct 13, 2026Oct 15, 2026
Page 227 of 1780
← PrevNext →
traded Oct 13, 2026
+2d
SEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$386K
1,544 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
MJ
Murphy Mark J.EVP & Chief Financial Officer
MUMICRON TECHNOLOGY INC
Option exercise
M—
22.8K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
MJ
Murphy Mark J.EVP & Chief Financial Officer
MUMICRON TECHNOLOGY INC
Option exercise
M—
22.8K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
MJ
Murphy Mark J.EVP & Chief Financial Officer
MUMICRON TECHNOLOGY INC
Option exercise
M—
19.3K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
MJ
Murphy Mark J.EVP & Chief Financial Officer
MUMICRON TECHNOLOGY INC
Grant or award
A—
24.5K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
MJ
Murphy Mark J.EVP & Chief Financial Officer
MUMICRON TECHNOLOGY INC
Grant or award
A—
24.5K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
MJ
Murphy Mark J.EVP & Chief Financial Officer
MUMICRON TECHNOLOGY INC
Grant or award
A—
27.2K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
MW
Martin Robert WDirector, CHIEF EXEC. AND PRES.
THOTHOR INDUSTRIES INC
Grant or award
A—
13.3K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
GK
Ghelani KekinSVP, Chief Strategy Officer
CMCCOMMERCIAL METALS Co
Tax withholding
F$39K
608 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$404K
1,611 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
TS
Taecker Benjamin S.Chief Eng and Opr Officer
AQMSAqua Metals, Inc.
Tax withholding
F$1,375
716 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
LM
Laughlin Whitney MChief Legal Officer
AMNAMN HEALTHCARE SERVICES INC
Option exercise
M—
4,976 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

9
WE
West EricChief Financial Officer
AQMSAqua Metals, Inc.
Tax withholding
F$1,657
863 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$414K
1,644 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
51.2K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

9
AI
Alexandria Venture Investments, LLC10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
1.03M sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
GJ
Grant Kevin J.CHIEF FINANCIAL OFFICER
AKAA.K.A. BRANDS HOLDING CORP.
Tax withholding
F$5,860
570 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
AR
Allen Scott R.CVP, Chief Accounting Officer
MUMICRON TECHNOLOGY INC
Grant or award
A—
9,081 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
KK
Kodama Wade KCFO
MLPMAUI LAND & PINEAPPLE CO INC
Tax withholding
F—
640 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
MM
McDermott MicheleChief Human Resources Officer
THOTHOR INDUSTRIES INC
Tax withholding
F$15K
233 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$81K
105 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$98K
127 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$51K
66 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$173K
224 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$163K
211 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$218K
283 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$56K
74 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$167K
219 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$214K
279 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$94K
121 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
CN
Chylak Robert NestorSenior Vice President
KLICKULICKE & SOFFA INDUSTRIES INC
Tax withholding
F$102K
1,157 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$207K
271 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$147K
192 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

7
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$517K
5,000 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

7
Silverman JoshDirector, Executive Chair of the Board
ETSYETSY INC
Option exercise · 10b5-1 plan
M—
417 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

7
Silverman JoshDirector, Executive Chair of the Board
ETSYETSY INC
Option exercise · 10b5-1 plan
M—
714 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Option exercise
M—
24.1K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Option exercise
M—
20.5K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence